How to manage ad partners in regulated industries: Pharma (part 5 of 5)
In the last of her five-part series, contributor Lori Weiman takes a deep dive into FDA guidelines and explains how pharmaceutical advertisers and their partners can avoid costly violations.
No comments:
Post a Comment